Ferguson Wellman Capital Management’s Estee Lauder EL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,025
Closed -$201K 353
2023
Q2
$201K Hold
1,025
﹤0.01% 353
2023
Q1
$253K Hold
1,025
0.01% 318
2022
Q4
$254K Sell
1,025
-20
-2% -$4.47K 0.01% 310
2022
Q3
$226K Hold
1,045
0.01% 280
2022
Q2
$266K Hold
1,045
0.01% 283
2022
Q1
$285K Hold
1,045
0.01% 288
2021
Q4
$387K Sell
1,045
-10
-0.9% -$3.39K 0.01% 267
2021
Q3
$316K Sell
1,055
-39
-4% -$12.7K 0.01% 282
2021
Q2
$348K Sell
1,094
-97
-8% -$29.4K 0.01% 278
2021
Q1
$346K Buy
1,191
+4
+0.3% +$1.09K 0.01% 270
2020
Q4
$316K Hold
1,187
0.01% 317
2020
Q3
$259K Hold
1,187
0.01% 317
2020
Q2
$224K Buy
+1,187
New +$212K 0.01% 313
2020
Q1
Sell
-1,157
Closed -$239K 320
2019
Q4
$239K Buy
1,157
+18
+2% +$3.5K 0.01% 325
2019
Q3
$227K Hold
1,139
0.01% 329
2019
Q2
$209K Buy
+1,139
New +$195K 0.01% 323
2013
Q3
Sell
-3,400
Closed -$224K 296
2013
Q2
$224K Buy
+3,400
New +$232K 0.02% 178

Other funds holding EL

Ferguson Wellman Capital Management's EL Position: Q3 2023 in Review

Ferguson Wellman Capital Management sold out of Estee Lauder (EL) in Q3 2023, closing a stake of 1,025 shares — an estimated $201K sold.

Ferguson Wellman Capital Management first reported a position in EL in Q2 2013 and held it in 17 quarters. The position peaked at $387K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold EL as of Q3 2023.

  • Ferguson Wellman Capital Management reported no remaining Estee Lauder position as of Q3 2023 after selling out during the quarter.
  • Ferguson Wellman Capital Management sold 1,025 Estee Lauder shares in Q3 2023, an estimated $201K.
  • Ferguson Wellman Capital Management first reported a position in Estee Lauder in Q2 2013 and held it in 17 quarters.
  • Ferguson Wellman Capital Management's Estee Lauder position peaked at $387K in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Estee Lauder as of Q3 2023.

Based on Ferguson Wellman Capital Management's 13F filing for Q3 2023, filed 12 Oct 2023.